An overview of sexually transmitted diseases. Part III ... - Dermatology

J AM ACAD DERMATOL
VOLUME 43, NUMBER 3
High-grade dysplasia in genital warts from two patients
infected with the human immunodeficiency virus. J Med Virol
1998;54:69-73.
159. Unger ER,Vernon SD, Lee DR, Miller DL, Sharma S, Clancy KA, et
al. Human papillomavirus type in anal epithelial lesions is
influenced by human immunodeficiency virus. Arch Pathol
Lab Med 1997;121:820-4.
160. Brown DR, Bryan JT, Cramer H, Katz BP, Handy V, Fife KH.
Detection of multiple human papillomavirus types in condyloma
acuminata from immunosuppressed patients. J Infect
Dis 1994;170:759-65.
161. Brown T, Tyring SK, Yen-Moore A. An overview of sexually transmitted
diseases. Part II. J Am Acad Dermatol 1999;41:661-77.
162. Modesto VL, Gottesman L. Sexually transmitted diseases and
anal manifestations of AIDS. Surg Clin North Am 1994;74:
1433-64.
163. Weiss EG, Wexner SD. Surgery for anal lesions in HIV-infected
patients. Ann Med 1995;27:467-75.
164. Kilewo CD, Urassa WK, Pallangyo K, Biberfeld G, Wigzell H.
Response to podophyllotoxin of genital warts in relation to
HIV-1 infection among patients in Dar es Salaam, Tanzania. Int
J STD AIDS 1995;6:114-6.
165. Petersen CS,Weismann K. Quercetin and kaempherol: an argument
against the use of podophyllin. Genitourin Med 1995;
71:92-3.
166. Zarcone R, Addonizio D, Voto RI, Cardone G, Di Stefano M,
Cardone A. Therapeutic prospects of natural alpha interferon
from normal human leucocytes in the treatment of genital
condylomata in HIV-positive women. Clin Exp Obstet Gynecol
1994;21:173-6.
167. Frega A, di Renzi P, Stanella P, Pachi A. Management of human
papillomavirus vulvo-perineal infection with systemic β-interferon
and thymostimulin in HIV-positive patients. Int J
Gynecol Obstet 1994;44:255-8.
168. Conant MA, Opp KM, Gilson RJC, Shupack JL, Friedman-Kien
AE, HPV Study Group. Imiquimod’s success in HIV-positive
patients with external genital warts. Presented as a poster
(#225) at the 56th Annual Meeting of the American Academy
of Dermatology, Orlando, Florida, Feb 27-March 4, 1998.
169. Tyring SK, Douglas J, Corey L, Kriesel J, Solomon L, Bowden B,
et al. A phase I/II study of cidofovir gel for refractory condyloma
acuminatum in patients with HIV infection. Presented as a
poster (#296) at the 55th Annual Meeting of the American
Academy of Dermatology, San Francisco, California, March 21-
26, 1997.
170. Orlando G, Fasolo MM, Signori R, Schiavini M, Casella A,
Cargnel A. Impact of highly active antiretroviral therapy on
clinical evolution of genital warts in HIV-1-infected patients.
AIDS 1999;13:291-3.
171. Reichert CM, O’Leary TJ, Levens DL, Simrell CR, Madner AM.
Autopsy pathology in the acquired immunodeficiency syndrome.
Am J Pathol 1983;112:357-82.
172. Matis WL, Triana A, Shapiro R, Eldred L, Polk BF, Hood HF.
Dermatologic findings associated with human immunodeficiency
virus infection. J Am Acad Dermatol 1987;17:746-51.
173. Hira SK, Wadhawan D, Kamanga J, Kavindele D, Macuacua R,
Patil PS, et al. Cutaneous manifestations of human immunodeficiency
virus in Lusaka, Zambia. J Am Acad Dermatol
1988;19:451-7.
174. Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum
of skin disease in patients infected with human immunodeficiency
virus. Arch Dermatol 1989;125:357-61.
175. Koopman RJJ, Van Merrienboer FCJ, Vreden SGS, Dolmans
WMV. Molluscum contagiosum: a marker for advanced HIV
infection. Br J Dermatol 1992;126:528-9.
176. Husak R, Garbe C, Orfanos CE. Mollusca contagiosa in HIV
Czelusta, Yen-Moore, and Tyring 429
infection: clinical manifestations in relation to immune status
and prognostic value in 39 patients. Hautarzt 1997;48:103-9.
177. Dann FJ, Tabibian P. Cutaneous diseases in human immunodeficiency
virus-infected patients referred to the UCLA
Immunosuppression Skin Clinic: reasons for referral and management
of selected diseases. Cutis 1995;55:85-8.
178. Schaub N, Gilli L, Rufli T, Gyr N, Battegay M, Nuesch R, et al.
Epidemiology of skin diseases in HIV-infected patients: a
prospective cohort study. Schweiz Rundsch Med Prax 1996;85:
1162-6.
179. Reynaud-Mendel B, Janier M, Gerbaka J, Hakim C, Rabian C,
Chastang C, et al. Dermatologic findings in HIV-1 infected
patients: a prospective study with emphasis on CD4+ cell
count. Dermatology 1996;192:325-8.
180. Mahe A, Bobin P, Coulibaly S, Tounkara A. Skin diseases disclosing
human immunodeficiency virus infection in Mali. Ann
Dermatol Venereol 1997;124:144-50.
181. Munoz-Perez MA, Rodriguez-Pichardo A, Camacho F,
Colmenero MA. Dermatological findings correlated with CD4
lymphocyte counts in a prospective 3 year study of 1161
patients with human immunodeficiency virus disease predominantly
acquired though intravenous drug abuse. Br J
Dermatol 1998;139:33-9.
182. Jung AC, Paauw DS. Diagnosing HIV-related disease: using the
CD4 count as a guide. J Gen Intern Med 1998;13:131-6.
183. Konya J, Thompson CH. Molluscum contagiosum virus: antibody
responses in persons with clinical lesions and seroepidemiology
in a representative Australian population. J Infect
Dis 1999;179:701-4.
184. Ficarra G, Cortes S, Rubino I, Romagnoli P. Facial and perioral
molluscum contagiosum in patients with HIV infection: a
report of eight cases. Oral Surg Oral Med Oral Pathol
1994;78:621-6.
185. Darai G, Reisner H, Scholz J, Schnitzler P, Lorbacher de Ruiz H.
Analysis of the genome of the molluscum contagiosum virus
by restriction endonuclease analysis and molecular cloning. J
Med Virol 1986;18:29-39.
186. Yamashita H, Uemura T, Kwashima M. Molecular epidemiologic
analysis of Japanese patients with molluscum contagiosum.
Int J Dermatol 1996;35:99-105.
187. Thompson CH, de Zwart-Steffe RT, Donovan B. Clinical and
molecular aspects of molluscum contagiosum infection in
HIV-1 positive patients. Int J STD AIDS 1992;3:101-6.
188. Schwartz JJ, Myskowski PL. Molluscum contagiosum in
patients with human immunodeficiency virus infection: a
review of twenty-seven patients. J Am Acad Dermatol 1992;
27:583-8.
189. Biswas J, Therese L, Kumarasamy N, Solomon S, Yesudian P. Lid
abscess with extensive molluscum contagiosum in a patient
with acquired immunodeficiency syndrome. Indian J
Opthalmol 1997;45:234-6.
190. Leahey AB, Shane JJ, Listhaus A,Trachtman M. Molluscum contagiosum
eyelid lesions as the initial manifestation of
acquired immunodeficiency syndrome. Am J Ophthalmol
1997;124:240-1.
191. Betlloch I, Pinazo I, Mestre F, Altes J, Villalonga C. Molluscum
contagiosum in human immunodeficiency virus infection:
response to zidovudine. Int J Dermatol 1989;28:351-2.
192. Redfield RR, James WD, Wright DC, Brown C, Salahuddin SZ,
Markham PO, et al. Severe molluscum contagiosum infection
in a patient with human T-cell lymphotrophic (HTLV-III) disease.
J Am Acad Dermatol 1985;13:821-4.
193. Gottlieb SL, Myskowski PL. Molluscum contagiosum. Int J
Dermatol 1994;33:453-61.
194. Williams LR, Webster G. Warts and molluscum contagiosum.
Clin Dermatol 1991;9:87-93.